128 related articles for article (PubMed ID: 38349796)
1. Targeting the glycan epitope type I N-acetyllactosamine enables immunodepletion of human pluripotent stem cells from early differentiated cells.
Rossdam C; Brand S; Beimdiek J; Oberbeck A; Albers MD; Naujok O; Buettner FFR
Glycobiology; 2024 Apr; 34(4):. PubMed ID: 38349796
[TBL] [Abstract][Full Text] [Related]
2. An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells.
Tang C; Lee AS; Volkmer JP; Sahoo D; Nag D; Mosley AR; Inlay MA; Ardehali R; Chavez SL; Pera RR; Behr B; Wu JC; Weissman IL; Drukker M
Nat Biotechnol; 2011 Aug; 29(9):829-34. PubMed ID: 21841799
[TBL] [Abstract][Full Text] [Related]
3. The binding specificity of the marker antibodies Tra-1-60 and Tra-1-81 reveals a novel pluripotency-associated type 1 lactosamine epitope.
Natunen S; Satomaa T; Pitkänen V; Salo H; Mikkola M; Natunen J; Otonkoski T; Valmu L
Glycobiology; 2011 Sep; 21(9):1125-30. PubMed ID: 21159783
[TBL] [Abstract][Full Text] [Related]
4. Pluripotent stem cells: Basic biology or else differentiations aimed at translational research and the role of flow cytometry.
Bose B; Nihad M; P SS
Cytometry A; 2023 May; 103(5):368-377. PubMed ID: 36918734
[TBL] [Abstract][Full Text] [Related]
5. Approach for Profiling of Glycosphingolipid Glycosylation by Multiplexed Capillary Gel Electrophoresis Coupled to Laser-Induced Fluorescence Detection To Identify Cell-Surface Markers of Human Pluripotent Stem Cells and Derived Cardiomyocytes.
Rossdam C; Konze SA; Oberbeck A; Rapp E; Gerardy-Schahn R; von Itzstein M; Buettner FFR
Anal Chem; 2019 May; 91(10):6413-6418. PubMed ID: 31058489
[TBL] [Abstract][Full Text] [Related]
6. Alterations of Glycosphingolipid Glycans and Chondrogenic Markers during Differentiation of Human Induced Pluripotent Stem Cells into Chondrocytes.
Xu L; Hanamatsu H; Homan K; Onodera T; Miyazaki T; Furukawa JI; Hontani K; Tian Y; Baba R; Iwasaki N
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33271874
[TBL] [Abstract][Full Text] [Related]
7. Characterization of novel antibodies that recognize sialylated keratan sulfate and lacto-N-fucopentaose I on human induced pluripotent cells: comparison with existing antibodies.
Nakao H; Yamaguchi T; Kawabata K; Higashi K; Nonaka M; Tuiji M; Nagai Y; Toyoda H; Yamaguchi Y; Kawasaki N; Kawasaki T
Glycobiology; 2023 Mar; 33(2):150-164. PubMed ID: 36373215
[TBL] [Abstract][Full Text] [Related]
8. A Cytotoxic Antibody Recognizing Lacto-N-fucopentaose I (LNFP I) on Human Induced Pluripotent Stem (hiPS) Cells.
Matsumoto S; Nakao H; Kawabe K; Nonaka M; Toyoda H; Takishima Y; Kawabata K; Yamaguchi T; Furue MK; Taki T; Okumura T; Yamazaki Y; Nakaya S; Kawasaki N; Kawasaki T
J Biol Chem; 2015 Aug; 290(33):20071-85. PubMed ID: 26100630
[TBL] [Abstract][Full Text] [Related]
9. Lectin binding profiles of SSEA-4 enriched, pluripotent human embryonic stem cell surfaces.
Venable A; Mitalipova M; Lyons I; Jones K; Shin S; Pierce M; Stice S
BMC Dev Biol; 2005 Jul; 5():15. PubMed ID: 16033656
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Residual Human-Induced Pluripotent Stem Cells in Human Chondrocytes by Cell Type-Specific Glycosphingolipid Glycome Analysis Based on the Aminolysis-SALSA Technique.
Miyazaki T; Hanamatsu H; Xu L; Onodera T; Furukawa JI; Homan K; Baba R; Kawasaki T; Iwasaki N
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905707
[TBL] [Abstract][Full Text] [Related]
11. New Monoclonal Antibodies to Defined Cell Surface Proteins on Human Pluripotent Stem Cells.
O'Brien CM; Chy HS; Zhou Q; Blumenfeld S; Lambshead JW; Liu X; Kie J; Capaldo BD; Chung TL; Adams TE; Phan T; Bentley JD; McKinstry WJ; Oliva K; McMurrick PJ; Wang YC; Rossello FJ; Lindeman GJ; Chen D; Jarde T; Clark AT; Abud HE; Visvader JE; Nefzger CM; Polo JM; Loring JF; Laslett AL
Stem Cells; 2017 Mar; 35(3):626-640. PubMed ID: 28009074
[TBL] [Abstract][Full Text] [Related]
12. Structural and quantitative evidence for dynamic glycome shift on production of induced pluripotent stem cells.
Hasehira K; Tateno H; Onuma Y; Ito Y; Asashima M; Hirabayashi J
Mol Cell Proteomics; 2012 Dec; 11(12):1913-23. PubMed ID: 23023295
[TBL] [Abstract][Full Text] [Related]
13. HLA and Histo-Blood Group Antigen Expression in Human Pluripotent Stem Cells and their Derivatives.
Säljö K; Barone A; Mölne J; Rydberg L; Teneberg S; Breimer ME
Sci Rep; 2017 Oct; 7(1):13072. PubMed ID: 29026098
[TBL] [Abstract][Full Text] [Related]
14. Application of a novel population of multipotent stem cells derived from skin fibroblasts as donor cells in bovine SCNT.
Pan S; Chen W; Liu X; Xiao J; Wang Y; Liu J; Du Y; Wang Y; Zhang Y
PLoS One; 2015; 10(1):e0114423. PubMed ID: 25602959
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibody K312-based depletion of pluripotent cells from differentiated stem cell progeny prevents teratoma formation.
Park J; Lee DG; Lee NG; Kwon MG; Son YS; Son MY; Bae KH; Lee J; Park JG; Lee NK; Min JK
BMB Rep; 2022 Mar; 55(3):142-147. PubMed ID: 34674794
[TBL] [Abstract][Full Text] [Related]
16. The cell surface glycosphingolipids SSEA-3 and SSEA-4 are not essential for human ESC pluripotency.
Brimble SN; Sherrer ES; Uhl EW; Wang E; Kelly S; Merrill AH; Robins AJ; Schulz TC
Stem Cells; 2007 Jan; 25(1):54-62. PubMed ID: 17008424
[TBL] [Abstract][Full Text] [Related]
17. Embryoglycan: a highly branched poly-N-acetyllactosamine in pluripotent stem cells and early embryonic cells.
Muramatsu T
Glycoconj J; 2017 Dec; 34(6):701-712. PubMed ID: 27188587
[TBL] [Abstract][Full Text] [Related]
18. Glycosphingolipid dynamics in human embryonic stem cell and cancer: their characterization and biomedical implications.
Ho MY; Yu AL; Yu J
Glycoconj J; 2017 Dec; 34(6):765-777. PubMed ID: 27549315
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of bone marrow-derived stage-specific embryonic antigen 1 positive pluripotent stem cells into male germ cells.
Shirazi R; Zarnani AH; Soleimani M; Nayernia K; Ragerdi Kashani I
Microsc Res Tech; 2017 Apr; 80(4):430-440. PubMed ID: 27990704
[TBL] [Abstract][Full Text] [Related]
20. A Novel Type of Stem Cells Double-Positive for SSEA-3 and CD45 in Human Peripheral Blood.
Sato T; Wakao S; Kushida Y; Tatsumi K; Kitada M; Abe T; Niizuma K; Tominaga T; Kushimoto S; Dezawa M
Cell Transplant; 2020; 29():963689720923574. PubMed ID: 32525407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
